跳至主要内容
临床试验/RBR-9mj2dt
RBR-9mj2dt已完成2 期

Effects of supplementation with Probiatop (mixture of probiotics) in the treatment of arterial hypertension

FarmoQuímica0 个研究点开始时间: 2020年2月27日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
20Y 至 50Y(—)
性别
Female

入选标准

  • women diagnosed with primary systemic arterial hypertension (SAH) and aged 20 to 50 years.

排除标准

  • Age <20 and> 50 years;
  • Patients with other associated morbidities with the exception of Diabetes Mellitus;
  • Patients with a history of angina, acute coronary syndrome, changes in
  • left ventricular ejection fraction;
  • Patients with changes in liver enzyme levels or kidney failure
  • (creatinine> 1.5 mg / dL);
  • Use of medications other than antihypertensives or
  • hypoglycemics;
  • Patient undergoing steroid or anticoagulant treatment, using
  • food supplements, with infections or neoplasia or other chronic pathology

研究者

发起方
FarmoQuímica

相似试验